Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
Study of Erlotinib in Combination With Bortezomib
- Status
- COMPLETED
- Phase
- PHASE1
Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715)
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Study of MK-0683 in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-098)
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Bortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease
- Status
- COMPLETED
- Phase
- PHASE2
PAD. ICORG 05-01, V11
- Status
- COMPLETED
- Phase
- PHASE2
Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma Patients
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2